Cumulus Neuroscience is at the forefront of developing advanced tools aimed at addressing significant healthcare challenges in neurodegeneration and psychiatry. Their flagship platform is a medical-grade, at-home data collection and analytics system designed to enhance the monitoring of functional brain health and disorders. This platform integrates neurophysiological monitoring, specifically through a first-in-class EEG headset, with various cognitive assessment tools that can be used in a home setting. By capturing objective longitudinal data across multiple modalities, the platform provides critical insights that facilitate faster and more effective clinical trials, ultimately improving the delivery of new therapies to patients.

The Cumulus platform leverages powerful machine learning analytics to analyze complex datasets, enabling the detection of subtle changes in patient conditions. It incorporates validated tools for assessing cognition, emotional bias through facial expression recognition, and language-based diagnostics for cognitive conditions. Additionally, the platform includes sleep assessment tools to measure sleep quality and staging remotely. By combining these diverse data sources within a secure cloud-based architecture, Cumulus Neuroscience aims to transform clinical trials in brain disorders, ensuring a more robust and cost-effective approach to treatment evaluation and patient care.

United Kingdom

Cumulus Neuroscience is a global digital health company focused on advancing neuroscience clinical trials and research. They collaborate with leading global pharmaceutical companies to meet the industry's complex clinical trial needs. Cumulus Neuroscience offers a unique career and is known for its innovative assessment platform for identifying brain disorders.

Cumulus Neuroscience

Company Details